Ebola Virus: Symptoms, Causes, and Prevention Explained

 Ebola Virus: Symptoms, Causes, and Prevention Explained

When news breaks about an Ebola outbreak in Africa, it is natural to feel concern—even if you live thousands of miles away. The images of healthcare workers in protective suits and reports of rising case counts can understandably raise anxiety. But what exactly is Ebola, how does it spread, and what should you actually know to stay informed and safe?

This guide provides a clear, evidence‑based overview of Ebola virus disease, including its symptoms, how it is transmitted, and the prevention measures that public health experts rely on.

Short medical disclaimer: This article is for educational purposes only and does not replace professional medical advice. If you have specific health concerns, please consult a qualified healthcare provider.

Quick summary

• Ebola is a severe, often fatal illness caused by orthoebolaviruses, with an average case fatality rate around 50%.

• The virus spreads to humans from infected animals (such as fruit bats) and then between people through direct contact with blood or other body fluids.

• Early symptoms resemble the flu, but the disease can progress to severe vomiting, diarrhoea, and sometimes bleeding.

• There are now licensed vaccines and antibody‑based treatments for the Zaire ebolavirus strain.

• For most readers in the US, UK, Canada, Australia, and Europe, the risk of Ebola remains extremely low.

Key takeaway

Ebola is a serious viral illness found mainly in Central and West Africa. While it has a high fatality rate, modern outbreak response—including rapid detection, contact tracing, safe burials, ring vaccination, and supportive care—has significantly improved survival. For people outside affected regions, the risk of infection is negligible.

Main explanation

What is Ebola virus disease?

Ebola virus disease (EVD)—formerly known as Ebola haemorrhagic fever—is a severe, often fatal illness that affects humans and other primates (such as monkeys, gorillas, and chimpanzees). The virus belongs to the Filoviridae family. There are several species of orthoebolaviruses, but only four are known to cause disease in humans: Zaire ebolavirus, Sudan ebolavirus, Bundibugyo ebolavirus, and Taï Forest ebolavirus.

The virus first appeared in 1976 in two simultaneous outbreaks—one in a village near the Ebola River in the Democratic Republic of the Congo (DRC), and another in a remote area of Sudan. Since then, there have been more than 40 documented outbreaks, with the vast majority occurring in sub‑Saharan Africa.

What are the symptoms of Ebola?

The time from exposure to the virus to the onset of symptoms—known as the incubation period—ranges from 2 to 21 days. A person infected with Ebola cannot spread the disease until they develop symptoms.

Symptoms typically appear suddenly and can be divided into early and later phases.

Early symptoms (often resemble the flu):

• Fever

• Severe fatigue and muscle pain

• Headache

• Sore throat

Later symptoms (usually appear after several days):

• Vomiting and diarrhoea

• Abdominal (stomach) pain

• Rash

• Impaired kidney and liver function

In less frequent cases, internal and external bleeding may occur—for example, oozing from the gums or blood in the stools. Bleeding manifestations occur in fewer than half of patients.

How common is bleeding in Ebola?

Despite its reputation as a “haemorrhagic fever,” severe internal and external bleeding is not universal. It tends to occur in a minority of cases, and the presence of bleeding is neither necessary for diagnosis nor the most common presentation. In modern clinical practice, the hallmark features are fever, gastrointestinal symptoms (vomiting and diarrhoea), and multiorgan dysfunction.

How is Ebola transmitted?

Ebola is a zoonotic disease, meaning it spreads from animals to humans. The natural reservoir of the virus is thought to be fruit bats of the Pteropodidae family. These bats can carry the virus without showing signs of illness. Other animals, such as non‑human primates (apes, monkeys) and duikers (small antelopes), can also become infected and serve as intermediate hosts.

Animal‑to‑human transmission can occur through direct contact with the blood, body fluids, or tissues of infected animals. This may happen during hunting, butchering, or consuming bushmeat.

Human‑to‑human transmission then drives outbreaks. The virus spreads through direct contact (through broken skin or mucous membranes) with:

• Blood, saliva, urine, stool, vomit, sweat, breast milk, or semen of an infected person.

• Surfaces and materials contaminated with these fluids—such as bedding, clothing, or used needles.

It is important to note that Ebola is not thought to spread through the air (for example, via droplets from coughing or sneezing). Close physical contact is required for transmission.

Who is most at risk?

During an outbreak, those at highest risk include:

• Healthcare workers caring for patients without adequate protective equipment.

• Family members and others in close contact with infected individuals.

• Mourners who have direct contact with the bodies of people who have died from Ebola during burial ceremonies.

What causes or contributes to the issue – the latest 2026 outbreak

Current outbreak in the Democratic Republic of the Congo

As of May 2026, a new Ebola outbreak has been declared in Ituri province, northeastern DRC—marking the country’s 17th recorded Ebola outbreak since 1976. The Africa Centres for Disease Control and Prevention (Africa CDC) confirmed the outbreak on May 15, 2026. As of the latest update, approximately 246 suspected cases and 65 deaths have been reported, mainly in the Mongwalu and Rwampara health zones.

Notably, preliminary laboratory results suggest the circulating strain is not Ebola Zaire—the species for which licensed vaccines and treatments exist. Sequencing is underway to confirm the exact species, which has significant implications for the response.

The outbreak has raised concerns due to the urban setting of Bunia, intense population movement, mining‑related mobility in Mongwalu, and insecurity in affected areas. Uganda has also confirmed an imported case—a 59‑year‑old Congolese man who died in Kampala, infected with the Bundibugyo strain, for which no vaccine currently exists.

What readers can safely do

For the vast majority of readers outside affected regions in Africa, the risk of Ebola is extremely low. However, understanding the facts and knowing how to act during travel is important.

If you are not traveling to an outbreak area:

• No special precautions are needed. Ebola is not a concern in daily life in the US, UK, Canada, Australia, or Europe unless you have had direct contact with a symptomatic person who has recently traveled from an outbreak zone.

• Stay informed through reliable public health sources such as the CDC, WHO, or the UK Health Security Agency (UKHSA).

If you are traveling to or living in an area with an active Ebola outbreak:

• Avoid direct contact with blood, body fluids, or tissues of infected people or animals.

• Do not handle items that may have come into contact with an infected person’s body fluids (e.g., bedding, clothing, medical equipment).

• Avoid funeral or burial rituals that involve direct handling of the deceased person’s body.

• Avoid contact with wild animals (especially fruit bats, monkeys, and apes) and do not consume bushmeat.

• Practice good hand hygiene – wash hands frequently with soap and water or use an alcohol‑based hand sanitizer.

• Seek medical care immediately if you develop fever, headache, muscle pain, or gastrointestinal symptoms and have had potential exposure to Ebola.

• Follow all guidance from local health authorities and outbreak response teams.

For healthcare workers:
If you are a healthcare professional who may encounter a patient with suspected Ebola, strictly adhere to infection prevention and control measures. This includes using appropriate personal protective equipment (PPE), screening patients for travel history and symptoms, and immediately notifying your local health department if Ebola is suspected. The CDC recommends rigorous training on the safe application and removal of PPE.

Common mistakes to avoid

• Assuming Ebola is airborne. This is a common misconception. Ebola requires direct contact with body fluids of a symptomatic person. It does not spread through the air like influenza or COVID‑19.

• Believing that Ebola is always a death sentence. While the average case fatality rate is around 50%, early intensive supportive care—including rehydration, electrolyte management, and treatment of specific symptoms—significantly improves survival. With monoclonal antibody treatments, survival rates can be much higher when patients receive care early.

• Delaying care due to fear of isolation. Ebola treatment centers are designed to safely manage patients and prevent spread. Early treatment saves lives.

• Handling a deceased person from Ebola without proper training. Burial ceremonies that involve direct contact with the body have been a major source of transmission. Safe and dignified burials are a critical part of outbreak control.

• Ignoring mild symptoms after possible exposure. Fever, headache, and muscle aches are the first signs. If you have been in an outbreak area, do not dismiss these symptoms—seek medical evaluation promptly.

Biology made simple

How the virus attacks the body

Once the Ebola virus enters the body (through broken skin or mucous membranes), it begins by infecting certain immune cells—specifically cells called macrophages and dendritic cells. From there, the virus spreads to the lymph nodes, then to the liver, spleen, and adrenal glands.

The virus effectively disables the immune system’s early warning system, allowing it to replicate rapidly. Infected cells release large amounts of inflammatory proteins called cytokines, which trigger a “cytokine storm”—an overwhelming immune response that damages blood vessels.

Damage to blood vessel walls leads to leaky vessels, dropping blood pressure, and, in some cases, bleeding problems. The virus also causes cell death in the liver and adrenal glands, leading to clotting abnormalities and organ failure. These effects, combined with severe fluid loss from vomiting and diarrhoea, can result in shock, multi‑organ failure, and death if not treated.

Understanding the terminology

• Orthoebolavirus – the scientific name for the group of viruses that cause Ebola disease.

• Zoonotic – a disease that spreads from animals to humans.

• Reservoir – an animal species that carries a virus without becoming sick, acting as a natural host.

• Incubation period – the time between exposure to a virus and the start of symptoms.

• Ring vaccination – a strategy where close contacts and contacts of contacts of a confirmed case are vaccinated to create a “ring” of immunity around the outbreak.

One realistic scenario (composite example, not a real patient)

“Marie, 32, is a healthcare worker in a city near the DRC border. When Ebola cases are confirmed in her region, her hospital implements screening protocols. One day, a patient arrives with fever, headache, and muscle pain. Marie checks the patient’s travel history—they had attended a funeral in an affected village where a person had died of an unexplained illness. Marie follows protocol: she isolates the patient, notifies public health authorities, and wears full PPE while caring for the patient. The patient tests positive for Ebola but recovers after receiving monoclonal antibody treatment and supportive care. Marie’s rapid action and adherence to infection control prevent further spread.”

Myth vs. fact

When to see a doctor

If you have traveled to an area with an active Ebola outbreak (or had contact with a confirmed case) AND you develop:

• Fever (temperature of 38.6°C / 101.5°F or higher)

• Severe headache

• Muscle and joint pain

• Fatigue

• Sore throat

• Later symptoms such as vomiting, diarrhoea, abdominal pain, or unexplained bleeding

Seek medical attention immediately. Before going to a clinic or hospital, call ahead and tell the healthcare staff about your travel history and symptoms. This allows them to prepare appropriate infection control measures and protect other patients and staff.

Do not delay. Early supportive care—rehydration and treatment of specific symptoms—improves survival. And do not assume your symptoms are something else (like malaria or the flu) without being evaluated, especially if you have an exposure history.

Guidance may vary by country, so check local health services or speak with a clinician.

2–3 smart questions to ask a clinician

1. “If I am planning travel to a region with an Ebola outbreak, what specific precautions should I take, and is vaccination available?”

2. “What symptoms should I watch for after returning from travel, and when should I seek medical evaluation?”

3. “For healthcare workers: What are our facility’s protocols for screening, isolation, and PPE use for suspected viral haemorrhagic fevers?”

Five frequently asked questions

1. Can Ebola be cured?
There is no specific cure, but early intensive supportive care—including intravenous fluids, electrolyte management, and treatment of complications—significantly improves survival. Monoclonal antibody treatments (ansuvimab and atoltivimab/maftivimab/odesivimab) are approved for the Zaire strain and have been shown to reduce mortality when given early.

2. Is there a vaccine for Ebola?
Yes. Two vaccines—Ervebo® (single dose) and the two‑dose Zabdeno® and Mvabea® regimen—are licensed for the Zaire ebolavirus strain. Ervebo is the only vaccine currently available in the global stockpile and is recommended for outbreak response. For other species (such as Sudan or Bundibugyo), no licensed vaccine currently exists, although candidates are in development.

3. How long does Ebola survive outside the body?
The virus can survive on surfaces for several hours to days, depending on conditions. It is inactivated by hospital‑grade disinfectants, heat (60°C / 140°F for 30 minutes), and ultraviolet light. This is why proper cleaning of contaminated surfaces and safe disposal of medical waste are critical.

4. Can you get Ebola from someone who has recovered?
Most survivors are no longer contagious once their blood tests confirm the virus is cleared. However, the virus can persist in certain body sites, including semen, for several weeks after recovery. The CDC advises male survivors to practice safer sex (using condoms) for at least 3 months after recovery or until their semen tests negative for the virus.

5. Should I worry about Ebola if I live in the US or Europe?
No. The risk of Ebola infection in the US, UK, Canada, Australia, and Europe remains extremely low. Most cases outside Africa have been in healthcare workers who traveled to outbreak zones or in travelers who had direct contact with symptomatic individuals. Public health systems have robust preparedness plans to quickly identify and isolate any imported case.

Written by:
Ibrahim Abdo, Health Content Specialist and Evidence‑Based Medical Writer focused on translating complex health information into clear, trustworthy, reader‑friendly insights.

Medical review status:
Not medically reviewed. This article was editorially fact‑checked and is for educational purposes only.

Published: May 16, 2026
Last updated: May 16, 2026

Editorial standard:
This article was created using evidence‑based sources and reviewed for clarity, accuracy, and reader safety.

Sources

1. World Health Organization (WHO). “Ebola virus disease.” https://www.who.int/health-topics/ebola. Accessed May 16, 2026.
   *Supports: Overview of Ebola, transmission, symptoms, average case fatality rate (50%), and treatment/prevention.*

2. World Health Organization (WHO). “Ebola virus disease vaccines.” https://www.who.int/news-room/questions-and-answers/item/ebola-vaccines. Published October 16, 2025. Accessed May 16, 2026.
   Supports: Information on Ervebo® and Zabdeno/Mvabea vaccines, ring vaccination, and global stockpile.

3. Centers for Disease Control and Prevention (CDC). “Clinical Guidance for Ebola Disease.” https://cdc.gov/ebola/hcp/clinical-guidance/index.html. Accessed May 16, 2026.
   Supports: Clinical guidance for healthcare providers, screening, infection control, and available FDA‑approved treatments.

4. Imperial College London. “Ebola outbreak 2026: Q&A with experts.” https://www.imperial.ac.uk/news/articles/2026/ebola-outbreak-2026-qa-with-experts/. Accessed May 16, 2026.
   Supports: Species of orthoebolaviruses, treatment limitations, and details on the May 2026 outbreak.

5. Africa Centres for Disease Control and Prevention (Africa CDC). “Africa CDC Calls Urgent Regional Coordination Meeting Following Ebola Virus Disease Outbreak in Ituri Province, DRC.” https://africacdc.org/news-item/africa-cdc-calls-for-urgent-regional-coordination-meeting-following-ebola-virus-disease-outbreak-in-ituri-province-drc/. Published May 15, 2026. Accessed May 16, 2026.
   Supports: 246 suspected cases, 65 deaths, non‑Zaire strain suspected, regional response coordination.

6. Global Biodefense. “Ebola Outbreak in Congo Triggers Emergency Regional Response as Cases Cross Into Uganda.” https://globalbiodefense.com/2026/05/15/ebola-outbreak-in-congo-triggers-emergency-regional-response-as-cases-cross-into-uganda/. Published May 15, 2026. Accessed May 16, 2026.
   Supports: Details of Ituri province outbreak, non‑Zaire strain, implications for vaccination, and cross‑border spread.

7. RTE News. “New Ebola virus outbreak in DR Congo kills 65.” https://www.rte.ie/news/world/2026/0516/1573638-ebola-outbreak-africa/. Published May 16, 2026. Accessed May 16, 2026.
   Supports: Uganda imported case (Bundibugyo strain), no vaccine available for this strain.

8. MSD Manual Consumer Version. “Ebola Virus and Marburg Virus Infections.” https://www.msdmanuals.com/home/infections/arboviruses-arenaviruses-filoviruses/ebola-virus-and-marburg-virus-infections. Reviewed/Revised August 2025. Accessed May 16, 2026.
   Supports: Transmission, symptoms, incubation period (2–21 days), and treatment with supportive care.

9. World Organisation for Animal Health (WOAH). “Ebola Virus Disease.” https://www.woah.org/en/disease/ebola-virus-disease/. Accessed May 16, 2026.
   Supports: Natural reservoir (fruit bats), animal‑to‑human transmission, and species of ebolaviruses.

10. National Emerging Special Pathogens Training and Education Center (NETEC). “Ebola Response and Clinical Updates: Care, Laboratory Coordination, and Infection Control for U.S. Healthcare Teams.” https://netec.org/2025/11/24/ebola-response-and-clinical-updates-care-laboratory-coordination-and-infection-control-for-u-s-healthcare-teams/. November 24, 2025. Accessed May 16, 2026.
    Supports: Epidemiology, symptoms, early recognition, travel history, and healthcare preparedness.